$NOV

NOV (NYSE:NOV) Beats Q2 CY2026 Sales Expectations

NOV (NYSE:NOV) reported Q2 CY2026 revenue of $2.13 billion, down 2.5% year on year but 2.4% above Wall Street estimates, and GAAP profit of $0.31 per share, 93.6% above consensus. The company said EBITDA margin rose to 13.3%. Free cash flow was negative, with $64 million burned in Q2.

Original reporting
Published Jul 28, 2026, 10:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 10:43 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
NOV (NYSE:NOV) Beats Q2 CY2026 Sales Expectations — source image
Decision brief

The 30-second read

$NOVBullishMed
01

Why it matters

Traders can weigh the earnings beat against cash deterioration and production weakness, which may influence estimates and positioning for subsequent quarters.

02

Market read

Q2 shows an earnings-quality split: profitability metrics beat, but cash generation worsened and production trends weakened.

03

What to watch

Free cash flow volatility versus WTI (25.4) and the 14.9% YoY drop in other production could drive skepticism despite accounting profitability.

Relevance 7/10Novelty 6/10Timing: after-hours/next-session reaction to Q2 results (stock up 4% to $20.63 immediately following)

Background

NOV is an oilfield equipment manufacturer serving drilling and production activity, so results are typically sensitive to upstream spending and crude prices.

Company-level read

Ticker impact

$NOVBullishMedium confidence
Context

NOV reported Q2 CY2026 revenue of $2.13B, down 2.5% YoY, but beating Wall Street estimates by 2.4%.

Expected impact

Near-term bias modestly positive on the beat, but follow-through may be capped by negative free cash flow and weaker production.

Evidence & confidence

The article provides concrete Q2 datapoints (revenue beat, GAAP EPS beat, EBITDA beat) plus cash deterioration (burned $64M, FCF turned negative) that can offset optimism.

Market effects

Signals mixed demand and cost discipline in oilfield services, with cash generation sensitivity to commodity swings remaining a concern.

No specific regional impact described beyond global oilfield capex sensitivity.

Oilfield equipment demand remains tied to crude-linked activity; cash volatility highlights exposure to global energy cycle swings.

Counterpoint

The revenue and EBITDA beats may reflect temporary cost scaling, while the negative free cash flow and other production decline point to underlying softness.

Key entities

  • NOV

    Oilfield equipment manufacturer reporting Q2 CY2026 results with revenue and GAAP EPS beats but YoY revenue decline and negative free cash flow.

Related articles

$NOVMedAI 8/10

Nov Inc. (NOV) Up 6.1% Since Last Earnings Report: Can It Continue?

Nov Inc. (NOV) shares rose 6.1% since its last earnings report, outperforming the S&P 500. Q2 adjusted earnings of 31 cents per share beat estimates, up 6.9% year-over-year, driven by Energy Equipment. Revenue of $2.1B beat estimates but fell 2.5% year-over-year. The company repurchased $63M in shares and paid $64M in dividends.

$VTOLMed

Oilfield Services Stocks Q2 Highlights: Bristow Group (NYSE:VTOL)

Valaris (VTOL) reported $539.2M revenue, down 12.4% YoY, beating estimates. ProPetro (PUMP) reported $305.8M revenue, down 6.2% YoY, missing estimates. NOV (NOV) reported $2.13B revenue, down 2.5% YoY, beating estimates. Helix Energy (HLX) reported $304M revenue, flat YoY, missing revenue but beating EPS and EBITDA estimates. All stocks rose post-earnings.

$NOVMedAI 8/10

NOV Earnings Reveal Improving Margins Amid Uneven Revenue Trends Today

NOV Inc. reported Q2 adjusted EPS of 31 cents, above the Zacks Consensus estimate of 16 cents, on revenue of $2.1 billion, also above expectations. Margins improved, with Energy Equipment EBITDA $200 million and a 16.4% margin. Revenues were mixed across segments, and management guided Q3 2026 revenue flat to up 2% and EBITDA $240–$270 million.

$NOVMed

NOV Inc. (NOV): Results of Operations and Financial Condition

NOV Inc. (NOV) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEWS Contact: Amie D'Ambrosio (713) 375-3826 FOR IMMEDIATE RELEASE NOV Reports Second quarter 2026 EARNINGS • Revenues of $2.13 billion, up 4% sequentially and down 2% year-over-year • Net income of $112 million, or $0.31 per share, an increase of $93 million sequent

$ACDCMedAI 9/10

ProFrac, NOV, and Borr Drilling Shares Are Falling, What You Need To Know

Shares of ProFrac (ACDC), NOV (NOV), and Borr Drilling (BORR) fell in the morning session after WTI crude dropped on progress in Iran–US peace-deal talks and renewed hopes for reopening the Strait of Hormuz. The article says lower oil prices typically lead producers to cut capex, reducing demand for drilling and completion services over the next 2–3 quarters.

$FROHighAI 8/10

Frontline plc (FRO): Financial results for Q2 2026

Frontline plc (FRO) furnished an SEC Form 6-K — earnings release. Exhibit 1 INTERIM FINANCIAL INFORMATION FRONTLINE PLC SECOND QUARTER 2026 28 August 2026 FRONTLINE PLC REPORTS RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2026 Frontline plc (the “Company”, “Frontline,” “we,” “us,” or “our”), today reported unaudited results for the six months